Inceptive website screenshot

Inceptive

Inceptive is an AI biotechnology company founded in 2021 by transformer co-author Jakob Uszkoreit and Stanford biochemist Rhiju Das, building foundation models of life to rationally design sequence-based medicines such as mRNA, siRNA, ASOs, and peptides. The company pairs large-scale deep learning with high-throughput in-house wet-lab experiments in a tight design-build-test loop, then licenses successful molecules to pharmaceutical partners. Inceptive is headquartered in Palo Alto with offices in Berlin and Zurich, is backed by a16z Bio + Health, Obvious Ventures, NVentures (NVIDIA), and S32, and has announced strategic collaborations including a multi-year agreement with Alnylam Pharmaceuticals. Inceptive is a research-partner biotech and does not currently publish a public API, developer portal, SDK, or documentation surface.

Inceptive is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Biotechnology, RNA, and Drug Discovery.

Inceptive’s developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyArtificial IntelligenceBiotechnologyRNADrug DiscoveryMachine LearningFoundation ModelsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/inceptive: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Inceptive Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: inceptive
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/inceptive.png
name: Inceptive
description: Inceptive is an AI biotechnology company founded in 2021 by transformer co-author Jakob Uszkoreit and Stanford
  biochemist Rhiju Das, building foundation models of life to rationally design sequence-based medicines such as mRNA, siRNA,
  ASOs, and peptides. The company pairs large-scale deep learning with high-throughput in-house wet-lab experiments in a tight
  design-build-test loop, then licenses successful molecules to pharmaceutical partners. Inceptive is headquartered in Palo
  Alto with offices in Berlin and Zurich, is backed by a16z Bio + Health, Obvious Ventures, NVentures (NVIDIA), and S32, and
  has announced strategic collaborations including a multi-year agreement with Alnylam Pharmaceuticals. Inceptive is a research-partner
  biotech and does not currently publish a public API, developer portal, SDK, or documentation surface.
url: https://raw.githubusercontent.com/api-evangelist/inceptive/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- obvious-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Artificial Intelligence
- Biotechnology
- RNA
- Drug Discovery
- Machine Learning
- Foundation Models
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/inceptive-domain-security.yml
- type: Website
  url: https://inceptive.com
- type: PrivacyPolicy
  url: https://inceptive.com/privacy-policy
- type: Blog
  url: https://inceptive.com/#media
- type: LinkedIn
  url: https://www.linkedin.com/company/inceptivenucleics/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence